新型冠状病毒肺炎疫情严重地区乳腺疾病患者的管理策略  被引量:1

The treatment proposal for the patients with breast diseases in the central epidemic area of 2019 coronavirus disease

在线阅读下载全文

作  者:赵璐 张林[1] 刘谨文 杨志芳[1] 沈文状 李兴睿[1] Zhao Lu;Zhang Lin;Liu Jinwen;Yang Zhifang;Shen Wenzhuang;Li Xingrui(Department of Thyroid and Breast Surgery,Tongji Hospital Affiliated with Tongji Medical College of Huazhong University of Science&Technology,Wuhan 430030,China)

机构地区:[1]华中科技大学同济医学院附属同济医院甲状腺乳腺外科,武汉430030

出  处:《中华外科杂志》2020年第5期331-336,共6页Chinese Journal of Surgery

摘  要:新型冠状病毒肺炎传染力强,人群易感性高,临床表现多样化,严重影响了群众正常的工作和生活,也影响了其他疾病的正常诊疗。乳腺疾病是临床常见病、多发病。在疫情严重地区,乳腺专科医师需要全面考虑疫情防控、疾病诊疗和医疗资源可及性等因素,合理选择诊疗方案,优化诊治流程;既避免新型冠状病毒肺炎的传播和交叉感染,也不延误疾病诊治。为此,我们依据相关诊疗规范和指南,结合实际工作经验,就疫情严重地区乳腺疾病诊疗问题提出有关策略建议。Currently,the epidemic of 2019 coronavirus disease(COVID-19)is still ongoing.Its characteristics include high contagiousness,herd susceptibility and clinical phenotype diversity,which have a severe influence on people′s daily life and rountine therapy for other diseases.Breast dieases are clinical common diseases.In the central epidemic area of COVID-19,the clinical specialists of breast diseases should consider all of the following factors comprehensively:the prevention of COVID-19,the diagnosis and treatment of breast diseases and the accessibility of medical resources.Besides,we should select the appropriate therapy and optimize treatment process so as to prevent the propagation and cross infection of COVID-19 as well as manage the breast diseases without delay.Therefore,we carried out some management proposals of the patients with breast diseases in the central epidemic area during the epidemic of COVID-19 on the basis of conventional treatment guidelines and clinical experiences.The suggestions and corrections from colleagues will be welcomed.

关 键 词:冠状病毒感染 新型冠状病毒肺炎 冠状病毒感染疾病-19 乳腺疾病 

分 类 号:R563[医药卫生—呼吸系统] R65[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象